Summary
We have investigated relations between hypotensive responses to LP-805, a newly synthesized vasodilator, and the production of nitric oxide (NO), in anesthetized rats. LP-805 (0.1–0.5 mg/kg, i.v.) or acetylcholine (ACh) (0.3 – 3.0 μg/kg, i.v.) caused a dose-dependent transient decrease in diastolic blood pressure. The decrease induced by 0.3 mg/kg LP-805 (i.v.) was partially inhibited by pretreatment with NG-nitro-l-arginine (LNNA), a specific inhibitor of endothelial NO synthase, but the responses to lower or higher doses of LP-805 (0.1 or 0.5 mg/kg, i.v.) were not affected. The dose-dependent decrease in diastolic blood pressure, caused by LP-805, was not affected by pretreatment with l- or d-arginine. The dose-dependent decrease in diastolic blood pressure caused by ACh was not affected by pretreatment with L-NNA or with l- or d-arginine. The hypotensive response to 20-min infusions of LP-805 (100 μg/kg per min) wassignificantly inhibited by pretreatment with L-NNA (10 mg/kg, i.v.). The half-recovery times (T1/2) of LP-805 or ACh-induced depressor responses were shortened by pretreatment with L-NNA. They were prolonged by l-arginine, but not by d-arginine. This shortening, by L-NNA, of the half-recovery time after LP-805 or ACh was reversed by l-arginine, but not by d-arginine. The T/2 of the LP-805-induced hypotensive response was not affected by pretreatment with indomethacin (1 mg/kg, i.v.). In the presence of L-NNA (10 mg/kg, i.v.), the T/2 of the LP-805-induced hypotensive response was not affected by pretreatment with indomethacin. The results suggest that the LP-805-induced hypotensive response may be related to direct or indirect activation of NO synthase in vascular endothelial cells, and to release of endothelium-derived NO.
Similar content being viewed by others
References
Aisaka K, Gross SS, Griffith OW, Levi R (1989a) NG-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: dose nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 160:881–886
Aisaka K, Gross SS, Griffith OW Levi R (1989b) l-Arginine availability determines the duration of acetylcholine-induced systemic vasodilatation in vivo. Biochem Biophys Res Commun 163: 710–717
Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 141:2407–2412
Doni MG, Whittle BJR, Palmer RMJ, Moncada S (1988) Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol 151:19–25
Gardiner SM, Compton AM, Bennett T, Palmer RMJ, Moncada S (1990a) Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15:484–492
Gardiner SM, Compton AM, Kemp PA, Bennett T (1990b) Regional and cardiac hemodynamic effects of NG-nitro-l-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol 101:625–631
Hecker M, Mitchell JA, Harris HJ, Katsura M, Thiemermann C, Vane JR (1990) Endothelial cells metabolize NG-monomethyl-l-arginine to l-citrulline and subsequently to l-arginine. Biochem Biophys Res Commun 167:1037–1043
Hibbs JB Jr, Vavrin Z, Taintor RR (1987) l-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138: 550–565
Ignarro LJ (1990) Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535–560
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci 84:9265–9269
Inazu M, Morimoto T, Momota Y, Kishii K, Tsujitani M, Yanaka M, Shiba T, Furukawa Y (1991) Cardiovascular effects of LP-805, a newly synthesized vasodilator, in dogs. Jpn J Pharmacol 55:[Suppl]329P
Moncada S, Higgs EA (eds) (1990) Nitric oxide from l-arginine: A bioregualtory system. Excerpta Medica, Amsterdam
Moncada S, Vane JR (1987) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30:293–331
Moncada S, Radomski MW Palmer RMJ (1988) Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37:2495–2501
Moncada S, Palmer RMJ, Higgs EA (1989) Biosynthesis of nitric oxide from l-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol 38:1709–1715
Nakashima M, Akata T, Kuriyama H (1992) Effects on the rabbit coronary artery of LP-805, a new type of releaser of endothelium-derived relaxing factor and a K+ channel opener. Cite Res 71: 852–869
Palmer RMJ, Moncada S (1989) A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 158:348–352
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526
Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 333:664–666
Rees DD, Palmer RMJ, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 86:3375–3378
Rees DD, Palmer RS, Schulz R, Hodson HF, Moncada S (1990) Characterization of three inhibitors of endothelial nitric oxide synthase on vitro and in vivo. Br J Pharmacol 101:746–752
Walder C, Thiemermann C, Vane JR (1991) The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 102:967–973
Yamazaki J, Fujita N, Nagao T (1991) NG-monomethyl-l-arginine-induced pressor response at developmental and established stage in spontaneously hypertensive rats. J Pharmacol Exp Ther 259:52–57
Yanaka M, Shikata Y, Sugiyma Y, Shiba T, Nishiki K Morimoto T, Momota Y, Tsujitani M, Furukawa Y (1991) Antihypertensive and antianginal actions of LP-805, a new vasodilating agent. Jpn J Pharmacol 55:[Suppl]330P
Author information
Authors and Affiliations
Additional information
Correspondence to M. Inazu at the above address
Rights and permissions
About this article
Cite this article
Inazu, M., Tujitani, M. Effect of LP-805, a releaser of endothelium-derived nitric oxide, on systemic vasodilatation in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 348, 178–183 (1993). https://doi.org/10.1007/BF00164796
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00164796